125 related articles for article (PubMed ID: 28684219)
1. Elevated plasma levels of miR-29a are associated with hemolysis in patients with hypertrophic cardiomyopathy.
Ntelios D; Meditskou S; Efthimiadis G; Pitsis A; Nikolakaki E; Girtovitis F; Parcharidou D; Zegkos T; Kouidou S; Karvounis H; Tzimagiorgis G
Clin Chim Acta; 2017 Aug; 471():321-326. PubMed ID: 28684219
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
4. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
Sonsöz MR; Yilmaz M; Cevik E; Orta H; Bilge AK; Elitok A; Onur I; Komurcu-Bayrak E
Heart Lung Circ; 2022 Feb; 31(2):199-206. PubMed ID: 34088630
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
Scolari FL; Faganello LS; Garbin HI; Piva E Mattos B; Biolo A
Int J Cardiol; 2021 Mar; 327():146-154. PubMed ID: 33212095
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy.
Huang D; Chen Z; Wang J; Chen Y; Liu D; Lin K
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868204
[TBL] [Abstract][Full Text] [Related]
7. Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.
Derda AA; Thum S; Lorenzen JM; Bavendiek U; Heineke J; Keyser B; Stuhrmann M; Givens RC; Kennel PJ; Schulze PC; Widder JD; Bauersachs J; Thum T
Int J Cardiol; 2015 Oct; 196():115-22. PubMed ID: 26086795
[TBL] [Abstract][Full Text] [Related]
8. Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy.
Ntelios D; Efthimiadis G; Zegkos T; Didagelos M; Katopodi T; Meditskou S; Parcharidou D; Karvounis H; Tzimagiorgis G
Hellenic J Cardiol; 2021; 62(5):349-354. PubMed ID: 32389629
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art.
Angelopoulos A; Oikonomou E; Vogiatzi G; Antonopoulos A; Tsalamandris S; Georgakopoulos C; Papanikolaou P; Lazaros G; Charalambous G; Siasos G; Vlachopoulos C; Tousoulis D
Curr Med Chem; 2021; 28(36):7400-7412. PubMed ID: 33820510
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker.
Dai Y; Dai D; Mehta JL
J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2181. PubMed ID: 25457411
[No Abstract] [Full Text] [Related]
11. Reply: MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker.
Condorelli G
J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2181-2. PubMed ID: 25457410
[No Abstract] [Full Text] [Related]
12. Association of circulating microRNA-122 and microRNA-29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers.
Sakai M; Spee B; Grinwis GCM; Penning LC; van Wolferen ME; van der Laan LJW; Fieten H
J Vet Intern Med; 2019 Jan; 33(1):151-157. PubMed ID: 30548329
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Kubo T; Okumiya T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Sugiura T; Doi YL; Kitaoka H
J Cardiol; 2016 Mar; 67(3):274-8. PubMed ID: 26254020
[TBL] [Abstract][Full Text] [Related]
14. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia.
Yamada A; Cox MA; Gaffney KA; Moreland A; Boland CR; Goel A
PLoS One; 2014; 9(11):e112481. PubMed ID: 25405754
[TBL] [Abstract][Full Text] [Related]
15. [Association between plasma microRNA-29a and left ventricular hypertrophy in patients with hypertension].
Yao SY; Liu J; Li Y; Wang M; Wang C; Xue H
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):215-220. PubMed ID: 30897881
[No Abstract] [Full Text] [Related]
16. LncRNA-MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR-29a-3p.
Zhou J; Zhou Y; Wang CX
J Cell Biochem; 2019 May; 120(5):7265-7275. PubMed ID: 30548303
[TBL] [Abstract][Full Text] [Related]
17. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs.
Shah JS; Soon PS; Marsh DJ
PLoS One; 2016; 11(4):e0153200. PubMed ID: 27054342
[TBL] [Abstract][Full Text] [Related]
19. Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy.
Liu Y; Afzal J; Vakrou S; Greenland GV; Talbot CC; Hebl VB; Guan Y; Karmali R; Tardiff JC; Leinwand LA; Olgin JE; Das S; Fukunaga R; Abraham MR
Front Cardiovasc Med; 2019; 6():170. PubMed ID: 31921893
[No Abstract] [Full Text] [Related]
20. Impact of Delayed Whole Blood Processing Time on Plasma Levels of miR- 1 and miR-423-5p up to 24 Hours.
Borges DP; Cunha-Neto E; Bocchi EA; Rigaud VOC
Microrna; 2018; 7(2):115-119. PubMed ID: 29564990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
